


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:04:04Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405976" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405976</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" id="eji70045" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">EJI</journal-id><journal-title-group><journal-title>European Journal of Immunology</journal-title></journal-title-group><issn pub-type="ppub">0014-2980</issn><issn pub-type="epub">1521-4141</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405976</article-id><article-id pub-id-type="pmcid-ver">PMC12405976.1</article-id><article-id pub-id-type="pmcaid">12405976</article-id><article-id pub-id-type="pmcaiid">12405976</article-id><article-id pub-id-type="pmid">40899087</article-id><article-id pub-id-type="doi">10.1002/eji.70045</article-id><article-id pub-id-type="publisher-id">EJI70045</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunity to Infection</subject><subj-group subj-group-type="heading"><subject>Research Article</subject><subj-group subj-group-type="heading"><subject>Basic</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Natural Killer Cells Are Dispensable for Virus Control in <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> Mice During Primary RSV Infection</article-title></title-group><contrib-group><contrib id="eji70045-cr-0001" contrib-type="author"><name name-style="western"><surname>Nakawesi</surname><given-names initials="J">Joy</given-names></name><xref rid="eji70045-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="eji70045-cr-0002" contrib-type="author"><name name-style="western"><surname>Sow Tao Min</surname><given-names initials="T">Tammie</given-names></name><xref rid="eji70045-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="eji70045-cr-0003" contrib-type="author" corresp="yes"><name name-style="western"><surname>Johansson</surname><given-names initials="C">Cecilia</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6607-5000</contrib-id><xref rid="eji70045-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>c.johansson@imperial.ac.uk</email></address></contrib></contrib-group><aff id="eji70045-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Respiratory Infections Section</named-content>
<institution>National Heart and Lung Institute, Imperial College London</institution>
<city>London</city>
<country country="GB">UK</country>
</aff><pub-date pub-type="epub"><day>03</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2025</year></pub-date><volume>55</volume><issue seq="20">9</issue><issue-id pub-id-type="pmc-issue-id">496084</issue-id><issue-id pub-id-type="doi">10.1002/eji.v55.9</issue-id><elocation-id>e70045</elocation-id><history><date date-type="rev-recd"><day>12</day><month>8</month><year>2025</year></date><date date-type="received"><day>29</day><month>8</month><year>2024</year></date><date date-type="accepted"><day>14</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">European Journal of Immunology</italic> published by Wiley&#8208;VCH GmbH.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="EJI-55-e70045.pdf"/><self-uri content-type="pdf" xlink:href="file:EJI-55-e70045.pdf"/><abstract><title>ABSTRACT</title><p>Respiratory syncytial virus (RSV) is one of the major causes of severe lower respiratory tract infections, especially in children, the elderly, and immunocompromised individuals. Complications arising from viral infections in these age groups can present therapeutic challenges, as most of these individuals have impaired adaptive immunity. Using the T&#8208; and B cell&#8208;deficient <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice, the mechanisms that mediate protection in immunocompromised hosts during RSV infection can be investigated. RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice showed no symptoms of disease or chronic inflammation in the lungs and airways despite the presence of infectious virus in their lungs several months after infection. Interestingly, Natural Killer (NK) cells, the main innate cells with anti&#8208;viral cytotoxic effector functions, were recruited 2 days earlier in the lungs of <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice compared with wildtype mice, resulting in early production of IFN&#8208;&#947;. However, depletion of NK cells did not affect disease severity or viral load. Together, these results suggest that the NK cells are largely dispensable for virus control during primary RSV infection in <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice.</p></abstract><abstract id="eji70045-abs-0001" abstract-type="graphical"><p>
<italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice are unable to clear respiratory syncytial virus (RSV) infection, despite an earlier recruitment of natural killer (NK) cells to the lungs compared with wild&#8208;type controls. Furthermore, depletion of NK cells does not affect viral load, indicating that alternative innate anti&#8208;viral mechanisms may compensate in the absence of adaptive immunity.
<boxed-text position="anchor" content-type="graphic" orientation="portrait"><graphic position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="EJI-55-e70045-g004.jpg"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="eji70045-kwd-0001">IFN&#8208;&#947;</kwd><kwd id="eji70045-kwd-0002">NK cells</kwd><kwd id="eji70045-kwd-0003">Rag2<sup>&#8722;/&#8722;</sup> mice</kwd><kwd id="eji70045-kwd-0004">respiratory syncytial virus</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>MRC</institution><institution-id institution-id-type="doi">10.13039/501100011856</institution-id></institution-wrap></funding-source><award-id>MR/V000659/1</award-id><award-id>MR/X001075/1</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Swedish Research Council International Postdoc</institution></institution-wrap></funding-source><award-id>2022&#8208;00191</award-id></award-group></funding-group><counts><fig-count count="5"/><table-count count="0"/><page-count count="12"/><word-count count="7614"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.2 mode:remove_FC converted:03.09.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="eji70045-cit-0001"><string-name name-style="western"><given-names>J.</given-names><surname>Nakawesi</surname></string-name>, <string-name name-style="western"><given-names>T.</given-names><surname>Sow Tao Min</surname></string-name>, and <string-name name-style="western"><given-names>C.</given-names><surname>Johansson</surname></string-name>, &#8220;<article-title>Natural Killer Cells Are Dispensable for Virus Control in <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> Mice During Primary RSV Infection</article-title>.&#8221; <source>European Journal of Immunology</source><volume>55</volume>, no. <issue>9</issue> (<year>2025</year>): <volume>55</volume>, <elocation-id>e70045</elocation-id>. <pub-id pub-id-type="doi">10.1002/eji.70045</pub-id><pub-id pub-id-type="pmid">40899087</pub-id><pub-id pub-id-type="pmcid">PMC12405976</pub-id></mixed-citation>
</p><fn-group><fn id="eji70045-note-0001"><p>
<bold>Funding</bold>: This study was supported by MRC (MR/V000659/1 and MR/X001075/1). JN was supported by the Swedish Research Council International Postdoc grant (2022&#8208;00191).</p></fn></fn-group></notes></front><body><sec id="eji70045-sec-0010"><label>1</label><title>Introduction</title><p>Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory tract infections in children [<xref rid="eji70045-bib-0001" ref-type="bibr">1</xref>]. Globally, RSV accounts for approximately 33 million acute lower respiratory infection episodes, 3.6 million hospital admissions, and 26,300 in&#8208;hospital deaths in children below 5 years. In healthy adults, RSV manifests as a mild illness. However, RSV infections cause significant morbidity and mortality in the elderly, especially those with pre&#8208;existing conditions, including immunocompromised individuals [<xref rid="eji70045-bib-0002" ref-type="bibr">2</xref>, <xref rid="eji70045-bib-0003" ref-type="bibr">3</xref>]. RSV infection does not result in long&#8208;lasting immunity, and thus reinfections are common [<xref rid="eji70045-bib-0004" ref-type="bibr">4</xref>]. Despite continued efforts for several decades, the current treatments for RSV are predominantly supportive care [<xref rid="eji70045-bib-0004" ref-type="bibr">4</xref>]. For prevention, monoclonal antibodies specific to the RSV fusion protein can be given to high&#8208;risk infants, and recently, RSV vaccines were licensed for use in adults above 60 years [<xref rid="eji70045-bib-0005" ref-type="bibr">5</xref>, <xref rid="eji70045-bib-0006" ref-type="bibr">6</xref>], or in pregnant women (to prevent RSV infections in infants) [<xref rid="eji70045-bib-0007" ref-type="bibr">7</xref>, <xref rid="eji70045-bib-0008" ref-type="bibr">8</xref>]. However, there is still a lot to uncover about the immune mechanisms driving disease severity during RSV infection.</p><p>RSV is a single&#8208;stranded, negative&#8208;sense RNA virus [<xref rid="eji70045-bib-0009" ref-type="bibr">9</xref>]. Upon infection of the host, RSV is recognised by pattern recognition receptors (PRRs) expressed on lung&#8208;resident cells, such as epithelial cells and alveolar macrophages (AMs), that initiate the antiviral innate immune response by secreting chemokines and cytokines such as type I interferons (IFNs) [<xref rid="eji70045-bib-0009" ref-type="bibr">9</xref>, <xref rid="eji70045-bib-0010" ref-type="bibr">10</xref>]. We have previously shown that AMs are the main producers of the initial type I IFNs in the lung during RSV infection [<xref rid="eji70045-bib-0011" ref-type="bibr">11</xref>]. Type I IFNs play a key role in limiting viral replication [<xref rid="eji70045-bib-0012" ref-type="bibr">12</xref>] but also regulate immune responses by promoting chemokines and cytokines that result in the recruitment and activation of immune cells, respectively [<xref rid="eji70045-bib-0013" ref-type="bibr">13</xref>, <xref rid="eji70045-bib-0014" ref-type="bibr">14</xref>]. Neutrophils are the first cells to be recruited to the lungs during RSV infection [<xref rid="eji70045-bib-0015" ref-type="bibr">15</xref>, <xref rid="eji70045-bib-0016" ref-type="bibr">16</xref>, <xref rid="eji70045-bib-0017" ref-type="bibr">17</xref>, <xref rid="eji70045-bib-0018" ref-type="bibr">18</xref>] by chemokines such as CXCL1 and CXCL2, which are detectable in the lungs as early as 4 to 8 h after virus exposure [<xref rid="eji70045-bib-0012" ref-type="bibr">12</xref>, <xref rid="eji70045-bib-0016" ref-type="bibr">16</xref>, <xref rid="eji70045-bib-0018" ref-type="bibr">18</xref>]. The next cell type to infiltrate the lung is the monocytes, which peak at day 2 post&#8208;infection [<xref rid="eji70045-bib-0011" ref-type="bibr">11</xref>]. Type I IFNs are key in recruiting inflammatory monocytes by inducing the production of monocyte chemoattractants such as CCL2 [<xref rid="eji70045-bib-0011" ref-type="bibr">11</xref>]. Natural killer (NK) cells are also recruited to the lungs, peaking at day 4 post&#8208;infection [<xref rid="eji70045-bib-0010" ref-type="bibr">10</xref>]. A study by Wang et&#160;al. [<xref rid="eji70045-bib-0019" ref-type="bibr">19</xref>] showed that the lungs have the highest percentage of NK cells, which also maintained a more mature phenotype, compared with other peripheral tissues. Furthermore, macrophages can enhance NK cell recruitment and activation via their early production of type I IFNs [<xref rid="eji70045-bib-0020" ref-type="bibr">20</xref>]. NK cells have been implicated in early defense against several respiratory viral infections by their production of anti&#8208;viral cytokines, such as IFN&#8208;gamma (IFN&#8208;&#947;), which can amplify the inflammatory response, and their secretion of granzymes and perforins, which directly kill infected cells [<xref rid="eji70045-bib-0021" ref-type="bibr">21</xref>, <xref rid="eji70045-bib-0022" ref-type="bibr">22</xref>, <xref rid="eji70045-bib-0023" ref-type="bibr">23</xref>]. For example, during respiratory vaccinia virus infection, NK cells were shown to be the primary source of IFN&#8208;&#947; before the arrival of CD8<sup>+</sup> T cells [<xref rid="eji70045-bib-0024" ref-type="bibr">24</xref>]. On the other hand, NK cell activity has been implicated in exacerbating pathology, promoting lung injury and mortality at the early stages of RSV [<xref rid="eji70045-bib-0025" ref-type="bibr">25</xref>] and influenza virus [<xref rid="eji70045-bib-0026" ref-type="bibr">26</xref>, <xref rid="eji70045-bib-0027" ref-type="bibr">27</xref>] infection in mice.</p><p>Adaptive immune responses are indispensable for viral clearance and protection from re&#8208; infection [<xref rid="eji70045-bib-0010" ref-type="bibr">10</xref>]. RSV&#8208;specific antibodies are generated after infection, and they are usually very effective in neutralising the virus [<xref rid="eji70045-bib-0028" ref-type="bibr">28</xref>, <xref rid="eji70045-bib-0029" ref-type="bibr">29</xref>, <xref rid="eji70045-bib-0030" ref-type="bibr">30</xref>]. However, they are poorly maintained and decline to pre&#8208;infection levels within a few months of infection, making them insufficient to prevent re&#8208;infection with RSV long&#8208;term [<xref rid="eji70045-bib-0010" ref-type="bibr">10</xref>, <xref rid="eji70045-bib-0031" ref-type="bibr">31</xref>]. T cells are also crucial in the defense against RSV, especially CD8<sup>+</sup> T cells, which have an important role in the clearance of the primary infection and limiting infection during secondary RSV infection [<xref rid="eji70045-bib-0010" ref-type="bibr">10</xref>, <xref rid="eji70045-bib-0032" ref-type="bibr">32</xref>, <xref rid="eji70045-bib-0033" ref-type="bibr">33</xref>, <xref rid="eji70045-bib-0034" ref-type="bibr">34</xref>, <xref rid="eji70045-bib-0035" ref-type="bibr">35</xref>].</p><p>In immunocompromised individuals, in whom the adaptive immune responses are impaired, it is not completely understood how the innate immune responses control RSV infection. In mouse models lacking functional T cells, complete viral clearance has been shown during influenza virus infection [<xref rid="eji70045-bib-0036" ref-type="bibr">36</xref>], while higher viral titres and increased airway inflammation were shown during RSV infection [<xref rid="eji70045-bib-0037" ref-type="bibr">37</xref>]. While the mechanisms that mediate protection in immunocompromised hosts are still unclear, in this study, we used the T&#8208; and B&#8208;cell&#8208;deficient <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice to investigate the innate immune responses that can mediate protection in the absence of adaptive immunity during primary RSV infection. We found that <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice were not susceptible to primary RSV infection but failed to fully clear the virus from their lungs and showed a long&#8208;term infection. <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice also showed an increased number of innate immune cells present in the lungs before infection. Interestingly, NK cells, which are the main innate immune cells with cytolytic activity, were recruited 2 days earlier in the lungs of <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice compared with wildtype mice, resulting in the early production of IFN&#8208;&#947;. However, depletion of NK cells did not affect disease severity or viral load, indicating that other innate anti&#8208;viral mechanisms are controlling RSV in immunocompromised <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> hosts.</p></sec><sec id="eji70045-sec-0020"><label>2</label><title>Results</title><sec id="eji70045-sec-0030"><label>2.1</label><title>
<italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> Mice Are Not Susceptible to Primary RSV Infection Despite Sustained Viral Load</title><p>As a few innate immune cells are always present in the lungs, we sought to first characterise the innate immune cells present in the lungs of uninfected C57BL/6 wildtype (Wt) or recombinant activation gene 2 knockout (<italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic>) mice. Both Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice had similar numbers of total lung cells (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0001" ref-type="fig">
<bold>1A</bold>
</xref>). Consistent with previous studies [<xref rid="eji70045-bib-0037" ref-type="bibr">37</xref>, <xref rid="eji70045-bib-0038" ref-type="bibr">38</xref>, <xref rid="eji70045-bib-0039" ref-type="bibr">39</xref>], we observed that uninfected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice had significantly more AMs, inflammatory monocytes, neutrophils, and NK cells in their lungs compared with Wt mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0001" ref-type="fig">
<bold>1B</bold>
</xref>
<bold>;</bold> for gating strategy, see <bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S1</bold>
</xref>). Rarer cell types such as innate lymphoid cells 1 and 2 (ILC1 and ILC2) were also increased in the lungs of uninfected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice compared with Wt mice (<bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S2</bold>
</xref>).</p><fig position="float" fig-type="FIGURE" id="eji70045-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>
<bold>Uninfected <italic toggle="yes">Rag2<sup>&#8722;</sup>
<sup>/</sup>
<sup>&#8722;</sup>
</italic> mice exhibit a higher number of innate immune cells in the lungs compared with Wt mice, yet they display a sustained viral load after primary RSV infection</bold>. Lung cells from uninfected Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice were analysed. (<bold>A</bold>) The total number of cells in the lungs. (<bold>B</bold>) The total number of alveolar macrophages (AMs; CD45<sup>+</sup>SiglecF<sup>+</sup>CD11c<sup>+</sup>), inflammatory monocytes (CD45<sup>+</sup>CD11b<sup>+</sup>CD64<sup>+</sup>), neutrophils (CD45<sup>+</sup>Ly6G<sup>+</sup>SiglecF<sup>&#8722;</sup>), and NK cells (CD45<sup>+</sup>CD49b<sup>+</sup>) enumerated in the lungs of uninfected mice. Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice were mock (PBS) or RSV&#8208;infected i.n. and the lungs were analysed at different time points after infection. (<bold>C, D</bold>) Weight loss is shown as the percentage of the original weight. (<bold>E</bold>) Lung viral load determined by RT&#8208;qPCR quantification of RSV <italic toggle="yes">L</italic> gene expression in lung tissue. (<bold>F</bold>) Infectious viral titer (focus&#8208;forming units) was measured in the lungs by immunoplaque assay. The detection limit is shown as a dotted line. Data are presented as the mean &#177; SEM of (<bold>A, B</bold>) <italic toggle="yes">n</italic>&#160;=&#160;29 Wt and <italic toggle="yes">n</italic>&#160;=&#160;26 <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice pooled from seven independent experiments, (<bold>C</bold>) <italic toggle="yes">n</italic>&#160;=&#160;8&#8211;10 mice/group pooled from two independent experiments, (<bold>D</bold>) <italic toggle="yes">n</italic>&#160;=&#160;3&#8211;6 mice from one experiment representative of two independent experiments. (<bold>E</bold>) Data are presented as the mean&#160;&#177;&#160;SEM of <italic toggle="yes">n</italic>&#160;=&#160;6&#8211;10 mice/group pooled from two independent experiments (day 0.75, 4, 7, and 56), <italic toggle="yes">n</italic>&#160;=&#160;10&#8211;13 mice/group pooled from three independent experiments (day 2), and <italic toggle="yes">n</italic>&#160;=&#160;3&#8211;5 mice/group from one experiment (day 28 and 217). PBS control groups are only shown until day 7. (<bold>F</bold>) Data are presented as the mean &#177; SEM <italic toggle="yes">n</italic>&#160;=&#160;4&#8211;5 Wt or <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> (day 4) and <italic toggle="yes">n</italic>&#160;=&#160;3&#8211;4 Wt and <italic toggle="yes">n</italic>&#160;=&#160;10 <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> (day 10) mice pooled from two independent experiments and <italic toggle="yes">n</italic>&#160;=&#160;5 Wt or <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> (day 217) mice from one experiment. Each symbol represents an individual mouse. Statistical significance was determined by (A, B, and F). Student's <italic toggle="yes">t</italic>&#8208;test, (C&#8211;E) one&#8208;way ANOVA with Tukey's post hoc test per time point, and only significance between RSV groups is shown. **<italic toggle="yes">p</italic>&#160;=&#160;0.01, ****<italic toggle="yes">p</italic>&#160;=&#160;0.0001. Symbols: open circle: Wt PBS; open square: <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> PBS; blue circle: Wt RSV; red square: <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> RSV.</p></caption><graphic position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="EJI-55-e70045-g005.jpg"/></fig><p>Since the anti&#8208;viral innate immune responses start immediately upon viral infections, we investigated the role of this response in the absence of a functional adaptive immune response during primary RSV infection. Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice were intranasally infected with RSV, and disease severity, measured by weight loss, and viral load were monitored. As expected, RSV&#8208;infected Wt mice lost about 7% of their original weight on day 6 post&#8208;infection (p.i.) and recovered by day 8 p.i. while no weight loss was observed in the <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice or the PBS controls (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0001" ref-type="fig">
<bold>1C</bold>
</xref>). In addition, none of the RSV&#8208;infected mice lost weight later during the infection (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0001" ref-type="fig">
<bold>1D</bold>
</xref>). Despite the lack of weight loss, RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice had significantly higher RSV <italic toggle="yes">L</italic> gene copy numbers as quantified by RT&#8208;qPCR on day 7 p.i. The RSV <italic toggle="yes">L</italic> gene was also detected in the <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice at 28, 56, and 217 days p.i. while the Wt mice had cleared the virus at these time points (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0001" ref-type="fig">
<bold>1E</bold>
</xref>). By using the RSV immunoplaque assay, it was confirmed that the infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice were harboring infectious virus for much longer than Wt mice, as live virus was still detectable 7 months p.i. (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0001" ref-type="fig">
<bold>1F</bold>
</xref>). Together, these results show that <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice do not develop symptoms or signs of RSV infection despite harbouring more virus and failing to fully clear the virus from their lungs.</p></sec><sec id="eji70045-sec-0040"><label>2.2</label><title>Kinetics of Innate Immune Cell Infiltration into the Lungs During RSV Infection in <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> Mice</title><p>Next, the kinetics of innate immune cell recruitment/infiltration into the lungs in both Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice were investigated during RSV infection (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>2A</bold>
</xref>). Both RSV&#8208;infected Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice had similar numbers of total cells and AMs in the lungs throughout the infection (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>2B</bold>
</xref>,<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>C</bold>
</xref>). Neutrophils are the first cells to be recruited into the lungs during RSV infection [<xref rid="eji70045-bib-0016" ref-type="bibr">16</xref>, <xref rid="eji70045-bib-0017" ref-type="bibr">17</xref>]. As expected, their numbers peaked in the lungs at 18&#160;h p.i. returning to baseline levels by day 4 p.i. RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice had significantly more neutrophils compared with the RSV&#8208;infected Wt mice throughout the infection (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>2D</bold>
</xref>). Inflammatory monocytes were recruited into the lungs of both RSV&#8208;infected Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice by 18&#160;h p.i. peaking at day 2 p.i. and returning to baseline levels by day 7 p.i. (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>2E</bold>
</xref>). The NK cell numbers were significantly higher in the RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice compared with the RSV&#8208;infected Wt mice throughout the infection. NK cells were recruited into the lungs of RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice earlier, at 18&#160;h p.i. peaking at day 2 p.i. and returning to baseline levels by day 7 p.i. (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>2F</bold>
</xref>,<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>G</bold>
</xref>). On the other hand, NK cells were recruited into the lungs of RSV&#8208;infected Wt mice at day 2 p.i., peaked at day 4 p.i., and returned to baseline levels by day 7 p.i. (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>2F</bold>
</xref>,<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>H</bold>
</xref>). Interestingly, the PBS&#8208;<italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice had a higher baseline of NK cells, at similar numbers to the NK cell numbers in the RSV&#8208;infected Wt mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>2F</bold>
</xref>). Altogether, these results show that innate immune cells are recruited into the lungs of both Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice during primary RSV infection, albeit the significantly higher numbers of neutrophils and NK cells recruited to the lungs of RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice. Despite the sustained viral load, <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice had no signs of chronic inflammation in the lungs (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>2</bold>
</xref>) or airways (<bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S3</bold>
</xref>).</p><fig position="float" fig-type="FIGURE" id="eji70045-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>
<bold>Innate immune cells in the lungs after RSV infection of <italic toggle="yes">Rag2<sup>&#8722;</sup>
<sup>/</sup>
<sup>&#8722;</sup>
</italic> and Wt mice</bold>. (A) Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice were mock (PBS) or RSV&#8208;infected i.n. and cells from the lungs were analysed at different time points after infection. (<bold>B</bold>) Total cells, (<bold>C</bold>) AMs, (<bold>D</bold>) neutrophils, (<bold>E</bold>) inflammatory monocytes, and (<bold>F</bold>) NK cells in the lungs, (<bold>G, H</bold>) NK cell data from (<bold>F</bold>) showing <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> and Wt mice separately. Data are presented as the mean&#160;&#177;&#160;SEM of <italic toggle="yes">n</italic>&#160;=&#160;7&#8211;9 mice/group pooled from two independent experiments (day 0.75), <italic toggle="yes">n</italic>&#160;=&#160;10&#8211;12 for PBS groups and <italic toggle="yes">n</italic>&#160;=&#160;22 for RSV&#8208;infected mice pooled from three or five independent experiments respectively (day 2), <italic toggle="yes">n</italic>&#160;=&#160;7&#8211;10 for PBS groups and <italic toggle="yes">n</italic>&#160;=&#160;14&#8211;16 for RSV&#8208;infected mice pooled from 2&#8211;3 or 3&#8211;4 independent experiments, respectively (day 4), <italic toggle="yes">n</italic>&#160;=&#160;3 for PBS groups (from one experiment) and <italic toggle="yes">n</italic>&#160;=&#160;9&#8211;10 for RSV&#8208;infected mice pooled from two independent experiments (day 7), and <italic toggle="yes">n</italic>&#160;=&#160;3&#8211;6 for PBS groups and <italic toggle="yes">n</italic>&#160;=&#160;7&#8211;10 for RSV&#8208;infected mice pooled from 1&#8211;2 or 2 independent experiments respectively (day 56). Statistical significance was determined by one&#8208;way ANOVA with Tukey's post hoc test per time point, and only significance between RSV groups is shown. *<italic toggle="yes">p</italic>&#160;&lt;&#160;0.05, **<italic toggle="yes">p</italic>&#160;&lt;&#160;0.01, ***<italic toggle="yes">p</italic>&#160;&lt;&#160;0.001, ****<italic toggle="yes">p</italic>&#160;&lt;&#160;0.0001. Symbols: open circle: Wt PBS; open square: <italic toggle="yes">Rag2<sup>&#8722;/&#8208;</sup>
</italic> PBS; blue circle: Wt RSV; red square: <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> RSV.</p></caption><graphic position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="EJI-55-e70045-g003.jpg"/></fig></sec><sec id="eji70045-sec-0050"><label>2.3</label><title>Early IFN&#8208;&#947; Production in <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> Mice During Primary RSV Infection</title><p>We assessed the expression of different cytokines, chemokines, and IFN&#8208;stimulated genes (ISGs) by RT&#8208;qPCR in the lungs of both RSV&#8208;infected Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice at 18&#160;h p.i. The expression of <italic toggle="yes">Tnfa</italic> and <italic toggle="yes">Il6</italic> was similar in both the Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> infected mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0003" ref-type="fig">
<bold>3A</bold>
</xref>,<xref rid="eji70045-fig-0003" ref-type="fig">
<bold>B</bold>
</xref>). <italic toggle="yes">Ifna5</italic> expression was significantly higher in the Wt compared with the <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0003" ref-type="fig">
<bold>3C</bold>
</xref>), but <italic toggle="yes">Ifnb</italic> and the ISGs, <italic toggle="yes">Mx1</italic> and <italic toggle="yes">Viperin</italic>, were expressed to the same levels in the lungs of Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> infected mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0003" ref-type="fig">
<bold>3D</bold>&#8211;<bold>F</bold>
</xref>). Since <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice lack a functional mature adaptive immune system, NK cells are the major cells present in these mice that are capable of secreting IFN&#8208;&#947;&#160;[<xref rid="eji70045-bib-0040" ref-type="bibr">40</xref>]. Therefore, IFN&#8208;&#947; levels were assessed in the BAL (airways) in both the Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice by ELISA. In line with our observations that NK cells are recruited already at 18&#160;h p.i. in RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>2F</bold>
</xref>), they also showed more IFN&#8208;&#947; at 18&#160;h p.i. (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0003" ref-type="fig">
<bold>3G</bold>
</xref>). Moreover, the IFN&#8208;&#947; response peaked at day 2 p.i. and returned to baseline levels by day 4 p.i. while in RSV&#8208;infected Wt mice, IFN&#8208;&#947; was only detectable at days 4 and 7 p.i. (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0003" ref-type="fig">
<bold>3G</bold>
</xref>) directly coinciding with NK and T cell recruitment into the lungs (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0002" ref-type="fig">
<bold>2H</bold>
</xref>; <bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S4</bold>
</xref>). Interestingly, the granzyme B levels in the BAL were similar in both groups of mice until day 7 p.i. when the RSV&#8208;infected Wt mice had a trend to more granzyme B compared with the RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice (<bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S5</bold>
</xref>). Together, these results show that the early NK cell recruitment and IFN&#8208;&#947; production in the lungs could account for the innate anti&#8208;viral mechanisms in the <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice during primary RSV infection.</p><fig position="float" fig-type="FIGURE" id="eji70045-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>
<bold>RSV Infection induces IFN&#8208;&#947; earlier in the lungs of <italic toggle="yes">Rag2<sup>&#8722;</sup>
<sup>/</sup>
<sup>&#8722;</sup>
</italic> mice compared with Wt mice</bold>. Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice were mock (PBS) or RSV&#8208;infected i.n. and the lungs were analysed at 18&#160;h (day 0.75) p.i. mRNA expression of (<bold>A</bold>) <italic toggle="yes">Tnfa</italic>, (<bold>B</bold>) <italic toggle="yes">Il6</italic>, (<bold>C</bold>) <italic toggle="yes">Ifna5</italic>, (<bold>D</bold>) <italic toggle="yes">Ifnb</italic>, (<bold>E</bold>) <italic toggle="yes">Mx1</italic>, and (<bold>F</bold>) <italic toggle="yes">Viperin</italic> was quantified by RT&#8208;qPCR in the lung tissue. (<bold>G</bold>) IFN&#8208;&#947; levels in the bronchoalveolar lavage fluid were analysed by ELISA at day 0.75, 2, 4, and 7 p.i. Data are presented as the mean&#160;&#177;&#160;SEM of (<bold>A</bold>&#8211;<bold>F</bold>) <italic toggle="yes">n&#160;</italic>=&#160;7&#8211;9 mice/group, pooled from two independent experiments. (<bold>G</bold>) <italic toggle="yes">n&#160;</italic>=&#160;7&#8211;8 mice/group pooled from two independent experiments (day 0.75), <italic toggle="yes">n&#160;</italic>=&#160;7&#8211;8 for PBS groups and <italic toggle="yes">n&#160;</italic>=&#160;12&#8211;14 for RSV&#8208;infected mice pooled from 2 or 3 independent experiments respectively (day 2 and 4) and <italic toggle="yes">n&#160;</italic>=&#160;3 for PBS groups (from one experiment) and <italic toggle="yes">n&#160;</italic>=&#160;9&#8211;10 for RSV&#8208;infected mice pooled from two independent experiments (day 7). Each symbol represents an individual mouse. Statistical significance was determined by one&#8208;way ANOVA with Tukey's post hoc test per time point, and only significance between RSV groups is shown. *<italic toggle="yes">p</italic>&#160;&lt;&#160;0.05, **<italic toggle="yes">p</italic>&#160;&lt;&#160;0.01, ***<italic toggle="yes">p</italic>&#160;&lt;&#160;0.001. Symbols: open circle: Wt PBS; open square: <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> PBS; blue circle: Wt RSV; red square: <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> RSV.</p></caption><graphic position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="EJI-55-e70045-g001.jpg"/></fig></sec><sec id="eji70045-sec-0060"><label>2.4</label><title>Cytokine Stimulation Promotes NK Cell Effector Functions, but NK Cells Are Dispensable for Viral Control During Primary RSV Infection</title><p>Cytokines such as IL&#8208;12 and IL&#8208;18 can directly activate and induce NK cells to produce IFN&#8208;&#947; and degranulate and release cytolytic effector molecules like granzymes [<xref rid="eji70045-bib-0019" ref-type="bibr">19</xref>, <xref rid="eji70045-bib-0041" ref-type="bibr">41</xref>, <xref rid="eji70045-bib-0042" ref-type="bibr">42</xref>]. To assess the effector functions of NK cells, lung cells were stimulated <italic toggle="yes">ex vivo</italic> with recombinant IL&#8208;12 and IL&#8208;18 for 4&#160;h. Restimulation of NK cells from the lungs of uninfected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> or Wt mice showed similar granzyme B and IFN&#8208;&#947; induction (<bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S6</bold>
</xref>), indicating that the ability of NK cells from a <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mouse to produce cytokines is not different to NK cells from a Wt mouse. Following up on our observations that the IFN&#8208;&#947; response peaked at day 2 p.i. and returned to baseline levels by day 4 p.i. in the RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0003" ref-type="fig">
<bold>3G</bold>
</xref>), recombinant IL&#8208;12 and IL&#8208;18 <italic toggle="yes">ex vivo</italic> stimulation of lung cells after RSV infection showed that indeed the number of NK cells producing intracellular IFN&#8208;&#947; and undergoing&#160;degranulation (as measured by surface expression of CD107a) peaked on day 2 p.i. and were decreased by day 4 p.i. in the RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice (<bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S7</bold>
</xref>). We thus analysed the NK cell effector functions in both the RSV&#8208;infected Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice on day 2 p.i. We observed that the number of NK cells that showed degranulation was significantly higher in <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice compared with Wt mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0004" ref-type="fig">
<bold>4A</bold>
</xref>,<xref rid="eji70045-fig-0004" ref-type="fig">
<bold>B</bold>
</xref>
<bold>;</bold>
<bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S7</bold>
</xref>). As anticipated, the number of NK cells producing intracellular IFN&#8208;&#947; and granzyme B (GrzmB) was higher in RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice compared with RSV&#8208;infected Wt mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0004" ref-type="fig">
<bold>4A</bold>
</xref>,<xref rid="eji70045-fig-0004" ref-type="fig">
<bold>C</bold>
</xref>,<xref rid="eji70045-fig-0004" ref-type="fig">
<bold>D</bold>
</xref>). However, the frequency of CD107a<sup>+</sup> NK cells were similar or lower in RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice compared with Wt mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0004" ref-type="fig">
<bold>4B</bold>
</xref>
<bold>;</bold>
<bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S7</bold>
</xref>), and the frequency of IFN&#8208;&#947; producing NK cells were similar in RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice compared with Wt mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0004" ref-type="fig">
<bold>4C</bold>
</xref>
<bold>;</bold>
<bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S7</bold>
</xref>), while the frequency of GrzmB producing NK cells were higher in RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice compared with Wt mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0004" ref-type="fig">
<bold>4D</bold>
</xref>). Altogether, these data suggest that NK cells in the lungs of both Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice are similarly activated to degranulate and to produce IFN&#8208;&#947; and granzyme B. However, because <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice have a higher number of NK cells, their overall effect may be more pronounced.</p><fig position="float" fig-type="FIGURE" id="eji70045-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>
<bold>Depletion of NK cells does not alter viral clearance in <italic toggle="yes">Rag2<sup>&#8722;</sup>
<sup>/</sup>
<sup>&#8722;</sup>
</italic> mice during RSV infection</bold>. Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice were RSV&#8208;infected i.n. On day 2 p.i., lung cells were stimulated ex vivo with IL&#8208;12 and IL&#8208;18 or PMA and ionomycin as a positive control. The cells were subsequently stained for surface CD107a, intracellular IFN&#8208;&#947;, and granzyme B. NK cells in the lungs were analysed using flow cytometry. (<bold>A</bold>) Representative flow cytometry plots showing CD107a, IFN&#8208;&#947;, and granzyme B on or in CD49b<sup>+</sup> NK cells (for gating strategy see Figure S1) from Wt or <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> mice after PBS, PMA+Ionomycin, or IL&#8208;12/IL&#8208;18 stimulation. Lung cells from RSV&#8208;infected Wt or <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> mice restimulated with IL&#8208;12/IL&#8208;18, and the total number and frequency of (<bold>B</bold>) CD107a<sup>+</sup>, (<bold>C</bold>) IFN&#8208;&#947;<sup>+</sup>, and (<bold>D</bold>) Granzyme B<sup>+</sup> NK cells were determined. (<bold>E</bold>) Representative flow cytometry plots of T and NK cells in the lungs of Wt or <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> mice with or without NK cell depletion on day 2 p.i. (<bold>F</bold>) The number of NK cells in the lungs of Wt or <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> mice after NK cell depletion on days 2 and 7 p.i. (<bold>G</bold>) Lung viral load determined by RT&#8208;qPCR quantification of RSV <italic toggle="yes">L</italic> gene expression in lung tissue on days 2 and 7 p.i. Data are presented as the mean&#160;&#177;&#160;SEM of (<bold>B&#8211;D</bold>) Wt <italic toggle="yes">n</italic>&#160;=&#160;14 mice and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup> n</italic>&#160;=&#160;11 mice pooled from two independent experiments. (<bold>E</bold>&#8211;<bold>G</bold>) Wt <italic toggle="yes">n</italic>&#160;=&#160;4&#8211;5 and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup> n</italic>&#160;=&#160;3 mice from one experiment, representative of two experiments (day 2), and Wt <italic toggle="yes">n</italic>&#160;=&#160;4 mice and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup> n</italic>&#160;=&#160;4&#8211;5 mice from one experiment (day 7). Each symbol represents an individual mouse. Statistical significance was determined by (B&#8211;D) Student's <italic toggle="yes">t</italic>&#8208;test and (F, G) one&#8208;way ANOVA with Tukey's post hoc test. *<italic toggle="yes">p</italic>&#160;&lt;&#160;0.05, **<italic toggle="yes">p</italic>&#160;&lt;&#160;0.01, ****<italic toggle="yes">p</italic>&#160;&lt;&#160;0.0001. Blue symbols: Wt RSV; red symbols: <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> RSV.</p></caption><graphic position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="EJI-55-e70045-g002.jpg"/></fig><p>Next, we assessed whether the earlier emergence of NK cell effector activity in RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice contributed to virus control in the lungs during primary RSV infection. NK cells were depleted in both Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice using an anti&#8208;NK1.1 antibody (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0004" ref-type="fig">
<bold>4E</bold>
</xref>,<xref rid="eji70045-fig-0004" ref-type="fig">
<bold>F</bold>
</xref>). After RSV infection, Wt mice, but not <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice, lose weight (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0001" ref-type="fig">
<bold>1C</bold>
</xref>
<bold>;</bold>
<bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S8A</bold>
</xref>). Interestingly, despite no detectable gene expression of IFN&#8208;&#947; in the lungs of NK cell&#8208;depleted <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice (<bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S8B</bold>
</xref>), there were no differences in weight loss (<bold>Figure</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S8A</bold>
</xref>) or RSV <italic toggle="yes">L</italic> gene copy numbers as quantified by RT&#8208;qPCR on days 2 and 7 p.i. between the NK cell&#8208;depleted and non&#8208;depleted Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> RSV&#8208;infected mice (<bold>Figure</bold>&#160;<xref rid="eji70045-fig-0004" ref-type="fig">
<bold>4G</bold>
</xref>). Altogether, these results indicate that although NK cells are recruited earlier to the lungs, they are dispensable for virus control during primary RSV infection in <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice.</p></sec></sec><sec id="eji70045-sec-0070"><label>3</label><title>Discussion</title><p>During viral infections, adaptive immunity is indispensable for viral clearance and protection from reinfection in mice [<xref rid="eji70045-bib-0033" ref-type="bibr">33</xref>, <xref rid="eji70045-bib-0043" ref-type="bibr">43</xref>, <xref rid="eji70045-bib-0044" ref-type="bibr">44</xref>]. Furthermore, immunocompromised people are more susceptible to respiratory infections, especially if they are lymphopenic [<xref rid="eji70045-bib-0045" ref-type="bibr">45</xref>, <xref rid="eji70045-bib-0046" ref-type="bibr">46</xref>, <xref rid="eji70045-bib-0047" ref-type="bibr">47</xref>]. In the present study, T&#8208; and B&#8208;cell&#8208;deficient <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice were used to investigate how RSV infection is altered in the absence of adaptive immunity. Consistent with previous studies [<xref rid="eji70045-bib-0037" ref-type="bibr">37</xref>, <xref rid="eji70045-bib-0038" ref-type="bibr">38</xref>, <xref rid="eji70045-bib-0039" ref-type="bibr">39</xref>], we found that uninfected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice had significantly more innate immune cells in their lungs compared with Wt mice. Overall, the innate immune response in RSV&#8208;infected Wt and <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice was similar, except that NK cells infiltrated the lungs earlier in <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice. This suggests that <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> mice may compensate for the absence of mature T&#8208; and B cells through early NK cell infiltration. However, this did not influence early viral load during RSV infection. Surprisingly, RSV&#8208;infected <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> mice harboured live infectious virus months after infection. Notably, despite this long&#8208;term sustained viral load, <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice exhibited no symptoms of disease (measured by weight loss or clinical signs) and showed no chronic inflammation in the lungs or airways.</p><p>There are many players involved in the control of lung viral infections. Type I IFNs, monocytes, NK cells, and T cells are key host mechanisms that control virus replication and spread [<xref rid="eji70045-bib-0010" ref-type="bibr">10</xref>, <xref rid="eji70045-bib-0013" ref-type="bibr">13</xref>]. After RSV&#8208;infection, the levels of type I IFNs, ISGs, monocytes, and neutrophils were very similar in <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice compared with Wt mice, and a difference in viral load was not observed until day 7 p.i. However, NK cells were recruited into the lungs of <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice as early as day 2 p.i., leading to an early production of IFN&#8208;&#947;. In line with our findings, Xiong et&#160;al. [<xref rid="eji70045-bib-0037" ref-type="bibr">37</xref>] showed that <italic toggle="yes">Rag2<sup>&#8722;/</sup>
</italic> mice had similar viral load as Wt mice until day 11 p.i. and then failed to fully clear the infection even though the mice had increased NK cells in peripheral blood. Furthermore, RSV&#8208;infected nude mice (lacking mature T cells) also showed increased viral load and airway inflammation compared with Wt BALB/c mice [<xref rid="eji70045-bib-0034" ref-type="bibr">34</xref>]. Indeed, since NK cells are the main innate immune cell population with anti&#8208;viral cytotoxic effector functions present in <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice [<xref rid="eji70045-bib-0021" ref-type="bibr">21</xref>, <xref rid="eji70045-bib-0022" ref-type="bibr">22</xref>, <xref rid="eji70045-bib-0023" ref-type="bibr">23</xref>, <xref rid="eji70045-bib-0045" ref-type="bibr">45</xref>], we reasoned that they might be the major drivers of viral control during primary RSV infection. To our surprise, this was not the case, as the NK cell&#8208;depleted, RSV&#8208;infected <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice showed no differences in viral load or disease severity as measured by weight loss.</p><p>Exploring the effect of NK cell depletion in other lung viral infections has reported different outcomes. One study using the respiratory vaccinia virus infection model showed that depletion of NK cells and/or IFN&#8208;&#947; in <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice significantly accelerated clinical manifestations, and mice succumbed more rapidly to vaccinia virus infection than the non&#8208;NK cell&#8208;depleted mice [<xref rid="eji70045-bib-0024" ref-type="bibr">24</xref>]. In contrast, when NK cells were depleted during influenza virus infection, one study showed significantly impaired viral clearance [<xref rid="eji70045-bib-0048" ref-type="bibr">48</xref>], while another study reported no effect on lung viral load [<xref rid="eji70045-bib-0027" ref-type="bibr">27</xref>]. However, several studies have reported less pathology in the lungs after influenza virus infection in NK cell&#8208;depleted mice [<xref rid="eji70045-bib-0026" ref-type="bibr">26</xref>, <xref rid="eji70045-bib-0027" ref-type="bibr">27</xref>], suggesting that NK cells can exacerbate pathology and promote mortality during influenza virus infection [<xref rid="eji70045-bib-0026" ref-type="bibr">26</xref>, <xref rid="eji70045-bib-0027" ref-type="bibr">27</xref>].</p><p>Although NK cells seem to play a dual role during viral infections, both aiding in viral control and contributing to immunopathology [<xref rid="eji70045-bib-0023" ref-type="bibr">23</xref>], our study suggests that NK cells and innate IFN&#8208;&#947; are not essential for limiting viral replication during RSV infection. While we do not establish a definitive role for NK cells in controlling disease severity, it remains unclear how their early recruitment and IFN&#8208;&#947; production in the lungs of <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice affect RSV infection. We believe that NK cells in <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> mice are fully functional. However, further investigation into their phenotype and their <italic toggle="yes">in situ</italic> location relative to the virus in the lungs at later time points would be valuable. Notably, Reilly et&#160;al. [<xref rid="eji70045-bib-0049" ref-type="bibr">49</xref>] reported elevated NK cells in the airways of children with severe RSV infection. In these children, circulating NK cells were decreased, and they exhibited impaired cytotoxicity [<xref rid="eji70045-bib-0049" ref-type="bibr">49</xref>], indicating that this altered NK cell phenotype is associated with severe RSV disease in infants. Taken together, these findings suggest that the severity of infection may influence the NK cell phenotype and their role in both viral clearance and immunopathology.</p><p>Interestingly, <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> mice do not show any weight loss at any time after primary RSV infection, even though the virus is not completely cleared from their lungs. Weight loss is dependent on the presence of T cells [<xref rid="eji70045-bib-0033" ref-type="bibr">33</xref>], but our data also suggest that T cells are important to completely clear the virus from the lungs. Different studies have reported that adoptive transfer of cytotoxic CD8<sup>+</sup> T cells helps to fully clear the persistent virus from the lungs of <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice during RSV [<xref rid="eji70045-bib-0033" ref-type="bibr">33</xref>, <xref rid="eji70045-bib-0044" ref-type="bibr">44</xref>], respiratory poxvirus [<xref rid="eji70045-bib-0050" ref-type="bibr">50</xref>], and vaccinia virus infection [<xref rid="eji70045-bib-0051" ref-type="bibr">51</xref>]. Since the innate NK cell&#8208;derived IFN&#8208;&#947; in <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice cannot fully compensate for the CD8<sup>+</sup> T cell&#8208;derived IFN&#8208;&#947;, one can argue that these two bursts of IFN&#8208;&#947; may be functionally different, and further studies are needed to fully characterise the importance of IFN&#8208;&#947; at different times post&#8208;infection in both viral control and immunopathology.</p><p>A better understanding of the factors that enable the <italic toggle="yes">Rag2<sup>&#8722;/&#8722;</sup>
</italic> mice to tolerate RSV without developing severe chronic inflammation in the lungs and airways will aid in the design of more effective treatments, prophylaxis, and vaccines to prevent complications from viral infections, particularly in immunocompromised individuals.</p><sec id="eji70045-sec-0080"><label>3.1</label><title>Data Limitations and Perspectives</title><p>The mechanisms controlling chronic viral infections in the lungs remain unclear. In this study, we demonstrate that NK cells, the major cytotoxic cells of the innate immune system, are dispensable for viral control during RSV infection in <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> mice on a C57BL/6 background. NK cells and ILC1 together comprise group 1 innate lymphoid cells [<xref rid="eji70045-bib-0052" ref-type="bibr">52</xref>, <xref rid="eji70045-bib-0053" ref-type="bibr">53</xref>]. Although NK cells are over 40 times more abundant than ILC1 in <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> mice, both cell types express NK1.1 and rapidly produce IFN&#8208;&#947; upon infection [<xref rid="eji70045-bib-0054" ref-type="bibr">54</xref>]. Therefore, our use of anti&#8208;NK1.1 antibodies may have, in addition to depleting NK cells, also depleted ILC1, complicating the interpretation of their individual roles. A major limitation of our study was the inability to clearly distinguish NK cells from ILC1 via flow cytometry [<xref rid="eji70045-bib-0055" ref-type="bibr">55</xref>], preventing a definitive assessment of their respective contributions to IFN&#8208;&#947; production and viral control. While ILC1 have been identified as the primary early source of IFN&#8208;&#947; during influenza virus infection in mice [<xref rid="eji70045-bib-0056" ref-type="bibr">56</xref>], our data suggest that both NK cells and ILC1 are dispensable for RSV control in this model.</p><p>It is also important to note that we used <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> mice on a C57BL/6 background, which is more resistant to RSV than other strains like BALB/c [<xref rid="eji70045-bib-0057" ref-type="bibr">57</xref>]. Future studies should explore the long&#8208;term role of NK cells in more severe models of RSV infection.</p></sec></sec><sec id="eji70045-sec-0090"><label>4</label><title>Materials and Methods</title><sec id="eji70045-sec-0100"><label>4.1</label><title>Ethics Approval Statement</title><p>All animal experiments were reviewed and approved by the Animal Welfare and Ethical Review Board (AWERB) within Imperial College London and approved by the UK Home Office in accordance with the Animals (Scientific Procedures) Act 1986.</p></sec><sec id="eji70045-sec-0110"><label>4.2</label><title>Mice</title><p>C57BL/6J (Wt) mice were purchased from Charles River, UK. <italic toggle="yes">Rag2</italic>
<sup>&#8722;/&#8722;</sup> mice were bred in&#8208;house (obtained from Marina Botto, Imperial College London). All animals were bred and housed in specific pathogen&#8208;free conditions. The mice were gender and age&#8208;matched (8&#8211;12 weeks) in each experiment.</p></sec><sec id="eji70045-sec-0120"><label>4.3</label><title>Virus and Infections</title><p>Plaque&#8208;purified human RSV A2 (originally from ATCC) was grown in HEp&#8208;2 cells (originally from ATCC) with DMEM (Sigma) supplemented with 2% fetal calf serum (FCS) (Sigma) and 2&#160;mM L&#8208;glutamine (Thermo Fisher). For infections, mice were transiently anesthetised with isoflurane and infected intranasally (i.n.) with 1.4&#160;&#215;&#160;10<sup>6</sup> focus&#8208;forming units (FFU) of RSV or phosphate&#8208;buffered saline (PBS) in 100&#160;&#181;l. The RSV titre was assessed in fresh lungs on the indicated days post&#8208;RSV infection using an immunoplaque assay (optimised from [<xref rid="eji70045-bib-0058" ref-type="bibr">58</xref>]). Briefly, lung homogenates were titrated on HEp&#8208;2 cell monolayers in six&#8208;well, flat&#8208;bottom plates and incubated for 2&#160;h at 37&#176;C 5% CO<sub>2</sub>. Then, pyruvate&#8208;free DMEM (Sigma) containing 2% FCS was added, and the plates were further incubated for 44&#160;h at 37&#176;C 5% CO<sub>2</sub>, before being fixed with methanol (Sigma) and 2% hydrogen peroxide (Sigma). Biotin&#8208;conjugated goat anti&#8208;RSV antibody (Biogenesis) was added to the plates and incubated for 2&#160;h at room temperature. Infected cells were detected using Extravidin&#8208;peroxidase (Sigma&#8208;Aldrich) and DAB substrate (diaminobenzidine tetrahydrochloride) (Sigma), enumerated by light microscopy, and used to calculate the viral titer as FFU.</p></sec><sec id="eji70045-sec-0130"><label>4.4</label><title>Isolation of Cells from the Airway (BAL) and Lung</title><p>On the indicated day post&#8208;RSV infection or PBS administration, mice were euthanised. The tracheae were exposed, and bronchoalveolar lavage (BAL) was performed by flushing the lungs three times with 1&#160;ml PBS containing 0.5&#160;mM EDTA (Life Technology, Paisley, UK). The fluid obtained was centrifuged at 6000&#160;rpm for 5&#160;min; supernatants were stored at &#8722;80&#176;C for cytokine detection, and cellular pellets were treated with ACK to remove red blood cells. Cells were enumerated via Trypan Blue (Sigma) exclusion and used for flow cytometry staining. For lung cells, mice were perfused with 10&#160;ml of PBS, and the lungs were excised. The top and middle&#8208;right lobes were snap frozen in liquid nitrogen for RNA extraction, and the remaining three lobes were collected into C&#8208;tubes (Miltenyi Biotech, UK) containing complete DMEM (cDMEM; DMEM supplemented with 10% FCS, 2&#160;mM L&#8208;glutamine, 100&#160;U/ml penicillin, and 100&#160;&#181;g/ml streptomycin), 1&#160;mg/ml Collagenase D (Roche, UK), and 30&#160;&#181;g/ml DNase I (Sigma Aldridge, UK) and processed with gentleMACS dissociator (Miltenyi Biotech) according to the manufacturer's protocol. Lungs were digested for 60&#160;min at 37&#176;C and further processed in the gentleMACS dissociator. Red blood cells were lysed using ACK buffer and then filtered using a 100&#160;&#181;m cell strainer. Cells were enumerated via Trypan Blue exclusion and used for flow cytometry staining.</p></sec><sec id="eji70045-sec-0140"><label>4.5</label><title>NK Cell in Vivo Depletion</title><p>Mice were depleted of NK cells using the anti&#8208;NK1.1 monoclonal antibody (PK136, eBioscience or AssayGenie) before and during RSV infection. 100&#160;&#181;g/mouse was given intranasally (i.n.) and 200&#160;&#181;g/mouse was given by intraperitoneal injection on day 1. 150&#160;&#181;g/mouse was then injected intraperitoneally every day for 2 days or 7 days. NK cell depletion was confirmed by flow cytometry of lung tissue for the presence of&#160;CD3<sup>&#8722;</sup>CD49b<sup>+</sup>&#160;NK cells.</p></sec><sec id="eji70045-sec-0150"><label>4.6</label><title>NK Cell Ex Vivo Stimulation and CD107a (LAMP1) Degranulation Assay&#8208;</title><p>To detect intracellular cytokines from NK cells, isolated lung cells were stimulated with recombinant IL&#8208;12 (5&#160;ng/ml; PeproTech, UK) and IL&#8208;18 (2.5&#160;ng/ml; Biolegend, Cambridge, UK) [<xref rid="eji70045-bib-0024" ref-type="bibr">24</xref>], left unstimulated (medium) or received phorbol 12&#8208;myristate 13&#8208;acetate (PMA) (100&#160;ng/ml) and ionomycin (300&#160;ng/ml) (Abcam) and incubated for 1&#160;h at 37&#176;C 5% CO<sub>2</sub>. Golgi Plug (BD Biosciences) was then added 1&#160;&#181;l per 2.5&#160;&#215;&#160;10<sup>6</sup> cells according to the manufacturer's instructions and incubated for 3 additional hours. To measure the NK cell degranulation activity, anti&#8208;mouse CD107a (1D4B, BV421, BioLegend) was added at 4&#160;&#181;g/ml to the cells during stimulation. Cells were then stained for flow cytometry analyses as described below.</p></sec><sec id="eji70045-sec-0160"><label>4.7</label><title>Flow Cytometry</title><p>2.5&#160;&#215;&#160;10<sup>6</sup> cells isolated from the lung or BAL cells were incubated with purified rat IgG2b anti&#8208;mouse CD16/CD32 receptor antibody (clone 93) for 20&#160;min at 4&#176;C (BioLegend). Cells were stained with fluorochrome&#8208;conjugated antibodies (<bold>Table</bold>
<xref rid="eji70045-supinfo-0001" ref-type="">
<bold>S1</bold>
</xref>) for 30&#160;min at 4&#176;C before fixing the cells with fixation buffer (BioLegend). For intracellular staining, the fixed cells were incubated with permeabilisation buffer for 15&#160;min, stained with fluorochrome&#8208;conjugated antibodies against granzyme B (GrzmB) and IFN&#8208;&#947; (XMG1.2) in the presence of purified rat IgG2b anti&#8208;mouse CD16/CD32 receptor antibody in permeabilisation buffer (BioLegend) for 1&#160;h. Samples were measured on a Becton Dickinson Fortessa. Data were analysed using FlowJo software (BD).</p></sec><sec id="eji70045-sec-0170"><label>4.8</label><title>RNA Extraction and Quantitative RT&#8208;PCR</title><p>Lung lobes were homogenized using a TissueLyser (Qiagen), and total RNA was extracted using a RNeasy Mini kit as described by the manufacturer (Qiagen), including the DNase step. RNA concentration was determined by NanoDrop (Thermo Scientific). Two micrograms of purified RNA was converted to cDNA using a High&#8208;Capacity RNA&#8208;to&#8208;cDNA kit according to the manufacturer's protocol (Applied Biosystems). RT&#8208;qPCR was performed with TaqMan Universal qPCR Master Mix (Qiagen) and the 7500 Fast Real&#8208;Time PCR System (Applied Biosciences). For relative mRNA expression for <italic toggle="yes">Il6</italic>, <italic toggle="yes">Ifna5, Viperin</italic>, and <italic toggle="yes">Mx1</italic> (all from Applied Biosystems), the &#916;CT was calculated for each target gene relative to <italic toggle="yes">Gapdh</italic> (encoding glyceraldehyde&#8208;3&#8208;phosphate dehydrogenase; Applied Biosystems) and expressed as 2<sup>&#8722;&#916;CT</sup>. For exact quantification of mRNA for <italic toggle="yes">Ifnb</italic>, <italic toggle="yes">Tnfa</italic>, <italic toggle="yes">Viperin</italic>, and RSV <italic toggle="yes">L gene</italic>, copy numbers were calculated from the DNA standard curve and normalised to a housekeeping gene, <italic toggle="yes">Gapdh</italic> (Applied Biosystems), as previously described [<xref rid="eji70045-bib-0011" ref-type="bibr">11</xref>]. Analysis was performed using the 7500 Fast System SDS Software</p></sec><sec id="eji70045-sec-0180"><label>4.9</label><title>Cytokine and Chemokine Detection</title><p>BAL supernatants were assessed for IFN&#8208;&#947; and Granzyme B using an ELISA kit (R&amp;D Systems, USA). Detection limits were 34&#160;pg/ml for IFN&#8208;&#947;, and 117&#160;pg/ml for GrzmB. The FLUOstar OMEGA plate reader (BMG Labtech) was used at an absorbance of 450&#160;nm. Data were analysed using the Omega/MARS data analysis software (BMG Labtech).</p></sec><sec id="eji70045-sec-0190"><label>4.10</label><title>Statistical Analysis</title><p>For a simple two&#8208;group comparison, an unpaired two&#8208;tailed Student's <italic toggle="yes">t</italic>&#8208;test was used. One ANOVA was used following Tukey's post hoc test for multiple comparisons. A value of <italic toggle="yes">p</italic>&#160;&lt;&#160;0.05 was considered significant for all tests. *<italic toggle="yes">p</italic>&#160;&lt;&#160;0.05; **<italic toggle="yes">p</italic>&#160;&lt;&#160;0.01; ***<italic toggle="yes">p</italic>&#160;&lt;&#160;0.001; ****<italic toggle="yes">p</italic>&#160;&lt;&#160;0.0001. Statistical analysis of data was performed using GraphPad Prism 10 (GraphPad Software Inc.).</p></sec></sec><sec id="eji70045-sec-0200"><title>Author Contributions</title><p>Joy Nakawesi designed, performed, and analysed the experiments. Tammie Sow Tao Min performed specific experiments and reviewed the paper. Cecilia Johansson supervised the project and designed the experiments. Joy Nakawesi and Cecilia Johansson wrote the paper.</p></sec><sec sec-type="COI-statement" id="eji70045-sec-0220"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="peer-review" id="eji70045-sec-0250"><title>Peer Review</title><p>The peer review history for this article is available at <ext-link xlink:href="https://publons.com/publon/10.1002/eji.70045" ext-link-type="uri">https://publons.com/publon/10.1002/eji.70045</ext-link>.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="eji70045-supinfo-0001" position="float" content-type="local-data" orientation="portrait"/><supplementary-material id="eji70045-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Supporting Figure 1</bold>: eji70045&#8208;sup&#8208;0001&#8208;SuppMat.pdf</p></caption><media xlink:href="EJI-55-e70045-s001.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="eji70045-sec-0210"><title>Acknowledgments</title><p>CJ is supported by grants from MRC (MR/V000659/1 and MR/X001075/1). JN was supported by the Swedish Research Council International Postdoc grant (2022&#8208;00191). We thank the staff of St Mary's flow cytometry facility and the St Mary's and Hammersmith animal facility for their assistance and members of the Johansson lab for scientific discussions. Experimental design illustrations were made using BioRender.</p></ack><sec sec-type="data-availability" id="eji70045-sec-0240"><title>Data Availability Statement</title><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></sec><ref-list id="eji70045-bibl-0001"><title>References</title><ref id="eji70045-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="eji70045-cite-0001"><string-name name-style="western"><given-names>Y.</given-names><surname>Li</surname></string-name>, <string-name name-style="western"><given-names>X.</given-names><surname>Wang</surname></string-name>, and <string-name name-style="western"><given-names>D. M.</given-names><surname>Blau</surname></string-name>, et&#160;al., &#8220;<article-title>Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections due to Respiratory Syncytial Virus in Children Younger Than 5 Years in 2019: A Systematic Analysis</article-title>,&#8221; <source>The Lancet</source><volume>399</volume> (<year>2022</year>): <fpage>2047</fpage>&#8211;<lpage>2064</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(22)00478-0</pub-id><pub-id pub-id-type="pmcid">PMC7613574</pub-id><pub-id pub-id-type="pmid">35598608</pub-id></mixed-citation></ref><ref id="eji70045-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="eji70045-cite-0002"><string-name name-style="western"><given-names>A. R.</given-names><surname>Falsey</surname></string-name>, <string-name name-style="western"><given-names>P. A.</given-names><surname>Hennessey</surname></string-name>, <string-name name-style="western"><given-names>M. A.</given-names><surname>Formica</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Cox</surname></string-name>, and <string-name name-style="western"><given-names>E. E.</given-names><surname>Walsh</surname></string-name>, &#8220;<article-title>Respiratory Syncytial Virus Infection in Elderly and High&#8208;risk Adults</article-title>,&#8221; <source>New England Journal of Medicine</source><volume>352</volume> (<year>2005</year>): <fpage>1749</fpage>&#8211;<lpage>1759</lpage>.<pub-id pub-id-type="pmid">15858184</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa043951</pub-id></mixed-citation></ref><ref id="eji70045-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="eji70045-cite-0003"><string-name name-style="western"><given-names>O.</given-names><surname>Chatzis</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Darbre</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Pasquier</surname></string-name>, et&#160;al., &#8220;<article-title>Burden of Severe RSV Disease Among Immunocompromised Children and Adults: A 10 Year Retrospective Study</article-title>,&#8221; <source>BMC Infectious Diseases</source><volume>18</volume> (<year>2018</year>): <fpage>111</fpage>.<pub-id pub-id-type="pmid">29510663</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12879-018-3002-3</pub-id><pub-id pub-id-type="pmcid">PMC5838875</pub-id></mixed-citation></ref><ref id="eji70045-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="eji70045-cite-0004"><string-name name-style="western"><given-names>H. H.</given-names><surname>Nam</surname></string-name> and <string-name name-style="western"><given-names>M. G.</given-names><surname>Ison</surname></string-name>, &#8220;<article-title>Respiratory Syncytial Virus Infection in Adults</article-title>,&#8221; <source>British Medical Journal</source><volume>366</volume> (<year>2019</year>): <elocation-id>l5021</elocation-id>.<pub-id pub-id-type="pmid">31506273</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.l5021</pub-id></mixed-citation></ref><ref id="eji70045-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="eji70045-cite-0005"><string-name name-style="western"><given-names>E. E.</given-names><surname>Walsh</surname></string-name>, <string-name name-style="western"><given-names>G.</given-names><surname>P&#233;rez Marc</surname></string-name>, and <string-name name-style="western"><given-names>A. M.</given-names><surname>Zareba</surname></string-name>, et&#160;al., &#8220;<article-title>Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults</article-title>,&#8221; <source>New England Journal of Medicine</source><volume>388</volume> (<year>2023</year>): <fpage>1465</fpage>&#8211;<lpage>1477</lpage>.<pub-id pub-id-type="pmid">37018468</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa2213836</pub-id></mixed-citation></ref><ref id="eji70045-bib-0006"><label>6</label><mixed-citation publication-type="miscellaneous" id="eji70045-cite-0006"><article-title>Healthcare Providers: RSV Vaccination for Adults 60 Years of Age and Over | CDC</article-title>, <ext-link xlink:href="https://www.cdc.gov/vaccines/vpd/rsv/hcp/older-adults.html" ext-link-type="uri">https://www.cdc.gov/vaccines/vpd/rsv/hcp/older&#8208;adults.html</ext-link> (<year>2023</year>).</mixed-citation></ref><ref id="eji70045-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="eji70045-cite-0007"><string-name name-style="western"><given-names>Z.</given-names><surname>Bebia</surname></string-name>, <string-name name-style="western"><given-names>O.</given-names><surname>Reyes</surname></string-name>, and <string-name name-style="western"><given-names>R.</given-names><surname>Jeanfreau</surname></string-name>, et&#160;al., &#8220;<article-title>Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial</article-title>,&#8221; <source>Journal of Infectious Diseases</source><volume>228</volume> (<year>2023</year>): <fpage>299</fpage>&#8211;<lpage>310</lpage>.<pub-id pub-id-type="pmid">36722147</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jiad024</pub-id><pub-id pub-id-type="pmcid">PMC10420396</pub-id></mixed-citation></ref><ref id="eji70045-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="eji70045-cite-0008"><string-name name-style="western"><given-names>A.</given-names><surname>Gunatilaka</surname></string-name> and <string-name name-style="western"><given-names>M. L.</given-names><surname>Giles</surname></string-name>, &#8220;<article-title>Maternal RSV Vaccine Development. Where to From Here?</article-title>,&#8221; <source>Human Vaccines Immunotherapy</source><volume>17</volume> (<year>2021</year>): <fpage>4542</fpage>&#8211;<lpage>4548</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/21645515.2021.1955608</pub-id><pub-id pub-id-type="pmcid">PMC8828132</pub-id><pub-id pub-id-type="pmid">34499565</pub-id></mixed-citation></ref><ref id="eji70045-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="eji70045-cite-0009"><string-name name-style="western"><given-names>C.</given-names><surname>Johansson</surname></string-name>, &#8220;<article-title>Respiratory Syncytial Virus Infection: An Innate Perspective</article-title>,&#8221; <source>F1000Research</source><volume>5</volume> (<year>2016</year>): <fpage>2898</fpage>.<pub-id pub-id-type="pmid">28105323</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12688/f1000research.9637.1</pub-id><pub-id pub-id-type="pmcid">PMC5224685</pub-id></mixed-citation></ref><ref id="eji70045-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="eji70045-cite-0010"><string-name name-style="western"><given-names>P. J. M.</given-names><surname>Openshaw</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Chiu</surname></string-name>, <string-name name-style="western"><given-names>F. J.</given-names><surname>Culley</surname></string-name>, and <string-name name-style="western"><given-names>C.</given-names><surname>Johansson</surname></string-name>, &#8220;<article-title>Protective and Harmful Immunity to RSV Infection</article-title>,&#8221; <source>Annual Review of Immunology</source><volume>35</volume> (<year>2017</year>): <fpage>501</fpage>&#8211;<lpage>532</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-immunol-051116-052206</pub-id><pub-id pub-id-type="pmid">28226227</pub-id></mixed-citation></ref><ref id="eji70045-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="eji70045-cite-0011"><string-name name-style="western"><given-names>M.</given-names><surname>Goritzka</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Makris</surname></string-name>, and <string-name name-style="western"><given-names>F.</given-names><surname>Kausar</surname></string-name>, et&#160;al., &#8220;<article-title>Alveolar Macrophage&#8211;derived Type I Interferons Orchestrate Innate Immunity to RSV Through Recruitment of Antiviral Monocytes</article-title>,&#8221; <source>Journal of Experimental Medicine</source><volume>212</volume> (<year>2015</year>): <fpage>699</fpage>&#8211;<lpage>714</lpage>.<pub-id pub-id-type="pmid">25897172</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20140825</pub-id><pub-id pub-id-type="pmcid">PMC4419339</pub-id></mixed-citation></ref><ref id="eji70045-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="eji70045-cite-0012"><string-name name-style="western"><given-names>F.</given-names><surname>McNab</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Mayer&#8208;Barber</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Sher</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Wack</surname></string-name>, and <string-name name-style="western"><given-names>A.</given-names><surname>O'Garra</surname></string-name>, &#8220;<article-title>Type I Interferons in Infectious Disease</article-title>,&#8221; <source>Nature Reviews Immunology</source><volume>15</volume> (<year>2015</year>): <fpage>87</fpage>&#8211;<lpage>103</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri3787</pub-id><pub-id pub-id-type="pmcid">PMC7162685</pub-id><pub-id pub-id-type="pmid">25614319</pub-id></mixed-citation></ref><ref id="eji70045-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="eji70045-cite-0013"><string-name name-style="western"><given-names>S.</given-names><surname>Makris</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Paulsen</surname></string-name>, and <string-name name-style="western"><given-names>C.</given-names><surname>Johansson</surname></string-name>, &#8220;<article-title>Type I Interferons as Regulators of Lung Inflammation</article-title>,&#8221; <source>Frontiers in Immunology</source><volume>8</volume> (<year>2017</year>): <fpage>259</fpage>.<pub-id pub-id-type="pmid">28344581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2017.00259</pub-id><pub-id pub-id-type="pmcid">PMC5344902</pub-id></mixed-citation></ref><ref id="eji70045-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="eji70045-cite-0014"><string-name name-style="western"><given-names>M.</given-names><surname>Goritzka</surname></string-name>, <string-name name-style="western"><given-names>L. R.</given-names><surname>Durant</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Pereira</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Salek&#8208;Ardakani</surname></string-name>, <string-name name-style="western"><given-names>P. J. M.</given-names><surname>Openshaw</surname></string-name>, and <string-name name-style="western"><given-names>C.</given-names><surname>Johansson</surname></string-name>, &#8220;<article-title>Alpha/Beta Interferon Receptor Signaling Amplifies Early Proinflammatory Cytokine Production in the Lung During respiratory Syncytial Virus Infection</article-title>,&#8221; <source>Journal of Virology</source><volume>88</volume> (<year>2014</year>): <fpage>6128</fpage>&#8211;<lpage>6136</lpage>.<pub-id pub-id-type="pmid">24648449</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.00333-14</pub-id><pub-id pub-id-type="pmcid">PMC4093897</pub-id></mixed-citation></ref><ref id="eji70045-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="eji70045-cite-0015"><string-name name-style="western"><given-names>P. S.</given-names><surname>McNamara</surname></string-name>, &#8220;<article-title>Bronchoalveolar Lavage Cellularity in Infants With Severe respiratory Syncytial Virus Bronchiolitis</article-title>,&#8221; <source>Archives of Disease in Childhood</source><volume>88</volume> (<year>2003</year>): <fpage>922</fpage>&#8211;<lpage>926</lpage>.<pub-id pub-id-type="pmid">14500316</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/adc.88.10.922</pub-id><pub-id pub-id-type="pmcid">PMC1719332</pub-id></mixed-citation></ref><ref id="eji70045-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="eji70045-cite-0016"><string-name name-style="western"><given-names>C.</given-names><surname>Johansson</surname></string-name> and <string-name name-style="western"><given-names>F. C. M.</given-names><surname>Kirsebom</surname></string-name>, &#8220;<article-title>Neutrophils in respiratory Viral Infections</article-title>,&#8221; <source>Mucosal Immunology</source><volume>14</volume> (<year>2021</year>): <fpage>815</fpage>&#8211;<lpage>827</lpage>.<pub-id pub-id-type="pmid">33758367</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41385-021-00397-4</pub-id><pub-id pub-id-type="pmcid">PMC7985581</pub-id></mixed-citation></ref><ref id="eji70045-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="eji70045-cite-0017"><string-name name-style="western"><given-names>F. C. M.</given-names><surname>Kirsebom</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Kausar</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Nuriev</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Makris</surname></string-name>, and <string-name name-style="western"><given-names>C.</given-names><surname>Johansson</surname></string-name>, &#8220;<article-title>Neutrophil Recruitment and Activation Are Differentially Dependent on MyD88/TRIF and MAVS Signaling During RSV Infection</article-title>,&#8221; <source>Mucosal Immunology</source><volume>12</volume> (<year>2019</year>): <fpage>1244</fpage>&#8211;<lpage>1255</lpage>.<pub-id pub-id-type="pmid">31358860</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41385-019-0190-0</pub-id><pub-id pub-id-type="pmcid">PMC6778055</pub-id></mixed-citation></ref><ref id="eji70045-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="eji70045-cite-0018"><string-name name-style="western"><given-names>A. R.</given-names><surname>Owen</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Farias</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Levins</surname></string-name>, et&#160;al., &#8220;<article-title>Exposure to Bacterial PAMPs Before RSV Infection Exacerbates Innate Inflammation and Disease via IL&#8208;1&#945; and TNF&#8208;&#945;</article-title>,&#8221; <source>Mucosal Immunology</source><volume>6</volume> (<year>2024</year>): <fpage>1184</fpage>&#8211;<lpage>1198</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mucimm.2024.08.002</pub-id><pub-id pub-id-type="pmcid">PMC11631774</pub-id><pub-id pub-id-type="pmid">39127259</pub-id></mixed-citation></ref><ref id="eji70045-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="eji70045-cite-0019"><string-name name-style="western"><given-names>J.</given-names><surname>Wang</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Li</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Zheng</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Sun</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Wei</surname></string-name>, and <string-name name-style="western"><given-names>Z.</given-names><surname>Tian</surname></string-name>, &#8220;<article-title>Lung Natural Killer Cells in Mice: Phenotype and Response to respiratory Infection</article-title>,&#8221; <source>Immunology</source><volume>137</volume> (<year>2012</year>): <fpage>37</fpage>&#8211;<lpage>47</lpage>.<pub-id pub-id-type="pmid">22612500</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2567.2012.03607.x</pub-id><pub-id pub-id-type="pmcid">PMC3449245</pub-id></mixed-citation></ref><ref id="eji70045-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="eji70045-cite-0020"><string-name name-style="western"><given-names>T.</given-names><surname>Salazar&#8208;Mather</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Lewis</surname></string-name>, and <string-name name-style="western"><given-names>C.</given-names><surname>Biron</surname></string-name>, &#8220;<article-title>Type I Interferons Regulate Inflammatory Cell Trafficking and Macrophage Inflammatory Protein 1alpha Delivery to the Liver</article-title>,&#8221; <source>Journal of Clinical Investigation</source><volume>110</volume> (<year>2002</year>): <fpage>321</fpage>&#8211;<lpage>330</lpage>.<pub-id pub-id-type="pmid">12163451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI15376</pub-id><pub-id pub-id-type="pmcid">PMC151088</pub-id></mixed-citation></ref><ref id="eji70045-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="eji70045-cite-0021"><string-name name-style="western"><given-names>P. R.</given-names><surname>Hesker</surname></string-name>, &#8220;<article-title>The Role of Natural Killer Cells in Pulmonary Immunosurveillance</article-title>,&#8221; <source>Frontiers in Bioscience</source><volume>S5</volume>, <fpage>575</fpage>&#8211;<lpage>587</lpage> (<year>2013</year>).<pub-id pub-id-type="doi" assigning-authority="pmc">10.2741/s391</pub-id><pub-id pub-id-type="pmcid">PMC4413461</pub-id><pub-id pub-id-type="pmid">23277070</pub-id></mixed-citation></ref><ref id="eji70045-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="eji70045-cite-0022"><string-name name-style="western"><given-names>F. J.</given-names><surname>Culley</surname></string-name>, &#8220;<article-title>Natural Killer Cells in Infection and Inflammation of the Lung</article-title>,&#8221; <source>Immunology</source><volume>128</volume> (<year>2009</year>): <fpage>151</fpage>&#8211;<lpage>163</lpage>.<pub-id pub-id-type="pmid">19740372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2567.2009.03167.x</pub-id><pub-id pub-id-type="pmcid">PMC2767305</pub-id></mixed-citation></ref><ref id="eji70045-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="eji70045-cite-0023"><string-name name-style="western"><given-names>R.</given-names><surname>Bhat</surname></string-name>, <string-name name-style="western"><given-names>M. A.</given-names><surname>Farrag</surname></string-name>, and <string-name name-style="western"><given-names>F. N.</given-names><surname>Almajhdi</surname></string-name>, &#8220;<article-title>Double&#8208;edged Role of Natural Killer Cells During RSV Infection</article-title>,&#8221; <source>International Reviews of Immunology</source><volume>39</volume> (<year>2020</year>): <fpage>233</fpage>&#8211;<lpage>244</lpage>.<pub-id pub-id-type="pmid">32469615</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08830185.2020.1770748</pub-id></mixed-citation></ref><ref id="eji70045-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="eji70045-cite-0024"><string-name name-style="western"><given-names>G.</given-names><surname>Abboud</surname></string-name>, <string-name name-style="western"><given-names>V.</given-names><surname>Tahiliani</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Desai</surname></string-name>, et&#160;al., &#8220;<article-title>Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense Against Respiratory Vaccinia Virus Infection</article-title>,&#8221; <source>Journal of Virology</source><volume>90</volume> (<year>2016</year>): <fpage>129</fpage>&#8211;<lpage>141</lpage>.<pub-id pub-id-type="pmid">26468539</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.01894-15</pub-id><pub-id pub-id-type="pmcid">PMC4702563</pub-id></mixed-citation></ref><ref id="eji70045-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="eji70045-cite-0025"><string-name name-style="western"><given-names>F.</given-names><surname>Li</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Zhu</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Sun</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Wei</surname></string-name>, and <string-name name-style="western"><given-names>Z.</given-names><surname>Tian</surname></string-name>, &#8220;<article-title>Natural Killer Cells Are Involved in Acute Lung Immune Injury Caused by Respiratory Syncytial Virus Infection</article-title>,&#8221; <source>Journal of Virology</source><volume>86</volume> (<year>2012</year>): <fpage>2251</fpage>&#8211;<lpage>2258</lpage>.<pub-id pub-id-type="pmid">22171263</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.06209-11</pub-id><pub-id pub-id-type="pmcid">PMC3302418</pub-id></mixed-citation></ref><ref id="eji70045-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="eji70045-cite-0026"><string-name name-style="western"><given-names>G.</given-names><surname>Zhou</surname></string-name>, <string-name name-style="western"><given-names>S. W. W.</given-names><surname>Juang</surname></string-name>, and <string-name name-style="western"><given-names>K. P.</given-names><surname>Kane</surname></string-name>, &#8220;<article-title>NK Cells Exacerbate the Pathology of Influenza Virus Infection in Mice: Innate Immunity</article-title>,&#8221; <source>European Journal of Immunology</source><volume>43</volume> (<year>2013</year>): <fpage>929</fpage>&#8211;<lpage>938</lpage>.<pub-id pub-id-type="pmid">23436540</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/eji.201242620</pub-id></mixed-citation></ref><ref id="eji70045-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="eji70045-cite-0027"><string-name name-style="western"><given-names>M. F.</given-names><surname>Abdul&#8208;Careem</surname></string-name>, <string-name name-style="western"><given-names>M. F.</given-names><surname>Mian</surname></string-name>, and <string-name name-style="western"><given-names>G.</given-names><surname>Yue</surname></string-name>, et&#160;al., &#8220;<article-title>Critical Role of Natural Killer Cells in Lung Immunopathology during Influenza Infection in Mice</article-title>,&#8221; <source>Journal of Infectious Diseases</source><volume>206</volume> (<year>2012</year>): <fpage>167</fpage>&#8211;<lpage>177</lpage>.<pub-id pub-id-type="pmid">22561366</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jis340</pub-id></mixed-citation></ref><ref id="eji70045-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="eji70045-cite-0028"><string-name name-style="western"><given-names>C.</given-names><surname>Verwey</surname></string-name> and <string-name name-style="western"><given-names>S. A.</given-names><surname>Madhi</surname></string-name>, &#8220;<article-title>Review and Update of Active and Passive Immunization against Respiratory Syncytial Virus</article-title>,&#8221; <source>BioDrugs</source><volume>37</volume> (<year>2023</year>): <fpage>295</fpage>&#8211;<lpage>309</lpage>.<pub-id pub-id-type="pmid">37097594</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40259-023-00596-4</pub-id><pub-id pub-id-type="pmcid">PMC10127166</pub-id></mixed-citation></ref><ref id="eji70045-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="eji70045-cite-0029"><string-name name-style="western"><given-names>Y. C.</given-names><surname>Bartsch</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Cizmeci</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Kang</surname></string-name>, et&#160;al., &#8220;<article-title>Antibody Effector Functions Are Associated With Protection From Respiratory Syncytial Virus</article-title>,&#8221; <source>Cell</source><volume>185</volume> (<year>2022</year>): <fpage>4873</fpage>&#8211;<lpage>4886</lpage>.<pub-id pub-id-type="pmid">36513064</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2022.11.012</pub-id></mixed-citation></ref><ref id="eji70045-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="eji70045-cite-0030"><string-name name-style="western"><given-names>D.</given-names><surname>Wilkins</surname></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Yuan</surname></string-name>, and <string-name name-style="western"><given-names>Y.</given-names><surname>Chang</surname></string-name>, et&#160;al., &#8220;<article-title>Durability of Neutralizing RSV Antibodies Following Nirsevimab Administration and Elicitation of the Natural Immune Response to RSV Infection in Infants</article-title>,&#8221; <source>Nature Medicine</source><volume>29</volume> (<year>2023</year>): <fpage>1172</fpage>&#8211;<lpage>1179</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-023-02316-5</pub-id><pub-id pub-id-type="pmcid">PMC10202809</pub-id><pub-id pub-id-type="pmid">37095249</pub-id></mixed-citation></ref><ref id="eji70045-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="eji70045-cite-0031"><string-name name-style="western"><given-names>M. S.</given-names><surname>Habibi</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Jozwik</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Makris</surname></string-name>, et&#160;al., &#8220;<article-title>Impaired Antibody&#8208;Mediated Protection and Defective IgA B&#8208;Cell Memory in Experimental Infection of Adults With Respiratory Syncytial Virus</article-title>,&#8221; <source>American Journal of Respiratory and Critical Care Medicine</source><volume>191</volume> (<year>2015</year>): <fpage>1040</fpage>&#8211;<lpage>1049</lpage>.<pub-id pub-id-type="pmid">25730467</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.201412-2256OC</pub-id><pub-id pub-id-type="pmcid">PMC4435460</pub-id></mixed-citation></ref><ref id="eji70045-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="eji70045-cite-0032"><string-name name-style="western"><given-names>I.</given-names><surname>Rossey</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Sedeyn</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>De Baets</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Schepens</surname></string-name>, and <string-name name-style="western"><given-names>X.</given-names><surname>Saelens</surname></string-name>, &#8220;<article-title>CD8+ T Cell Immunity Against Human Respiratory Syncytial Virus</article-title>,&#8221; <source>Vaccine</source><volume>32</volume> (<year>2014</year>): <fpage>6130</fpage>&#8211;<lpage>6137</lpage>.<pub-id pub-id-type="pmid">25223272</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2014.08.063</pub-id></mixed-citation></ref><ref id="eji70045-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="eji70045-cite-0033"><string-name name-style="western"><given-names>M. J.</given-names><surname>Cannon</surname></string-name>, <string-name name-style="western"><given-names>P. J.</given-names><surname>Openshaw</surname></string-name>, and <string-name name-style="western"><given-names>B. A.</given-names><surname>Askonas</surname></string-name>, &#8220;<article-title>Cytotoxic T Cells Clear Virus but Augment Lung Pathology in Mice Infected With Respiratory Syncytial Virus</article-title>,&#8221; <source>Journal of Experimental Medicine</source><volume>168</volume> (<year>1988</year>): <fpage>1163</fpage>&#8211;<lpage>1168</lpage>.<pub-id pub-id-type="pmid">3262705</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.168.3.1163</pub-id><pub-id pub-id-type="pmcid">PMC2189034</pub-id></mixed-citation></ref><ref id="eji70045-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="eji70045-cite-0034"><string-name name-style="western"><given-names>J.</given-names><surname>Zhou</surname></string-name>, <string-name name-style="western"><given-names>X.</given-names><surname>Yang</surname></string-name>, and <string-name name-style="western"><given-names>Z.</given-names><surname>Fu</surname></string-name>, et&#160;al., &#8220;<article-title>Increased Pathogenesis and Inflammation of Airways From Respiratory Syncytial Virus Infection in T Cell Deficient Nude Mice</article-title>,&#8221; <source>Medical Microbiology and Immunology</source><volume>197</volume> (<year>2008</year>): <fpage>345</fpage>&#8211;<lpage>351</lpage>.<pub-id pub-id-type="pmid">18058127</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00430-007-0067-9</pub-id></mixed-citation></ref><ref id="eji70045-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="eji70045-cite-0035"><string-name name-style="western"><given-names>A.</given-names><surname>Jozwik</surname></string-name>, <string-name name-style="western"><given-names>M. S.</given-names><surname>Habibi</surname></string-name>, and <string-name name-style="western"><given-names>A.</given-names><surname>Paras</surname></string-name>, et&#160;al., &#8220;<article-title>RSV&#8208;specific Airway Resident Memory CD8+ T Cells and Differential Disease Severity After Experimental Human Infection</article-title>,&#8221; <source>Nature Communications</source><volume>6</volume> (<year>2015</year>): <elocation-id>10224</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncomms10224</pub-id><pub-id pub-id-type="pmcid">PMC4703893</pub-id><pub-id pub-id-type="pmid">26687547</pub-id></mixed-citation></ref><ref id="eji70045-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="eji70045-cite-0036"><string-name name-style="western"><given-names>M.</given-names><surname>Eichelberger</surname></string-name>, <string-name name-style="western"><given-names>W.</given-names><surname>Allan</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Zijlstra</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Jaenisch</surname></string-name>, and <string-name name-style="western"><given-names>P. C.</given-names><surname>Doherty</surname></string-name>, &#8220;<article-title>Clearance of Influenza Virus respiratory Infection in Mice Lacking Class I Major Histocompatibility Complex&#8208;Restricted CD8+ T Cells</article-title>,&#8221; <source>Journal of Experimental Medicine</source><volume>174</volume> (<year>1991</year>): <fpage>875</fpage>&#8211;<lpage>880</lpage>.<pub-id pub-id-type="pmid">1919440</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.174.4.875</pub-id><pub-id pub-id-type="pmcid">PMC2118969</pub-id></mixed-citation></ref><ref id="eji70045-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="eji70045-cite-0037"><string-name name-style="western"><given-names>R.</given-names><surname>Xiong</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Fu</surname></string-name>, and <string-name name-style="western"><given-names>Y.</given-names><surname>Wu</surname></string-name>, et&#160;al., &#8220;<article-title>Long&#8208;Term Infection and Pathogenesis in a Novel Mouse Model of Human Respiratory Syncytial Virus</article-title>,&#8221; <source>Viruses.</source><volume>14</volume> (<year>2022</year>): <fpage>1740</fpage>.<pub-id pub-id-type="pmid">36016362</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/v14081740</pub-id><pub-id pub-id-type="pmcid">PMC9415064</pub-id></mixed-citation></ref><ref id="eji70045-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="eji70045-cite-0038"><string-name name-style="western"><given-names>L.</given-names><surname>Rolfes</surname></string-name>, <string-name name-style="western"><given-names>T.</given-names><surname>Ruck</surname></string-name>, and <string-name name-style="western"><given-names>C.</given-names><surname>David</surname></string-name>, et&#160;al., &#8220;<article-title>Natural Killer Cells Are Present in Rag1&#8208;/&#8208; Mice and Promote Tissue Damage during the Acute Phase of Ischemic Stroke</article-title>,&#8221; <source>Translational Stroke Research</source><volume>13</volume> (<year>2022</year>): <fpage>197</fpage>&#8211;<lpage>211</lpage>.<pub-id pub-id-type="pmid">34105078</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12975-021-00923-3</pub-id><pub-id pub-id-type="pmcid">PMC8766401</pub-id></mixed-citation></ref><ref id="eji70045-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="eji70045-cite-0039"><string-name name-style="western"><given-names>K.</given-names><surname>Kaur</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Kanayama</surname></string-name>, <string-name name-style="western"><given-names>Q.</given-names><surname>Wu</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Gumrukcu</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Nishimura</surname></string-name>, and <string-name name-style="western"><given-names>A.</given-names><surname>Jewett</surname></string-name>, &#8220;<article-title>Zoledronic Acid Mediated Differential Activation of NK Cells in Different Organs of WT and Rag2&#8208;/&#8208; Mice; Stark Differences Between the Bone Marrow and Gingivae</article-title>,&#8221; <source>Cellular Immunology</source><volume>375</volume> (<year>2022</year>): <elocation-id>104526</elocation-id>.<pub-id pub-id-type="pmid">35500335</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cellimm.2022.104526</pub-id></mixed-citation></ref><ref id="eji70045-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="eji70045-cite-0040"><string-name name-style="western"><given-names>C. G.</given-names><surname>Feng</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Kaviratne</surname></string-name>, and <string-name name-style="western"><given-names>A. G.</given-names><surname>Rothfuchs</surname></string-name>, et&#160;al., &#8220;<article-title>NK Cell&#8208;Derived IFN&#8208;&#947; Differentially Regulates Innate Resistance and Neutrophil Response in T Cell&#8208;Deficient Hosts Infected with <italic toggle="yes">Mycobacterium tuberculosis</italic>
</article-title>,&#8221; <source>Journal of Immunology</source><volume>177</volume> (<year>2006</year>): <fpage>7086</fpage>&#8211;<lpage>7093</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.177.10.7086</pub-id><pub-id pub-id-type="pmid">17082625</pub-id></mixed-citation></ref><ref id="eji70045-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="eji70045-cite-0041"><string-name name-style="western"><given-names>M.</given-names><surname>Tomura</surname></string-name>, <string-name name-style="western"><given-names>X.</given-names><surname>Zhou</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Maruo</surname></string-name>, et&#160;al., &#8220;<article-title>A Critical Role for IL&#8208;18 in the Proliferation and Activation of NK1.1+CD3&#8722; Cells</article-title>,&#8221; <source>Journal of Immunology</source><volume>160</volume> (<year>1998</year>): <fpage>4738</fpage>&#8211;<lpage>4746</lpage>.<pub-id pub-id-type="pmid">9590219</pub-id></mixed-citation></ref><ref id="eji70045-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="eji70045-cite-0042"><string-name name-style="western"><given-names>B. R.</given-names><surname>Lauwerys</surname></string-name>, <string-name name-style="western"><given-names>J. C.</given-names><surname>Renauld</surname></string-name>, and <string-name name-style="western"><given-names>F. A.</given-names><surname>Houssiau</surname></string-name>, &#8220;<article-title>Synergistic Proliferation and Activation of Natural Killer Cells by Interleukin 12 and Interleukin 18</article-title>,&#8221; <source>Cytokine</source><volume>11</volume> (<year>1999</year>): <fpage>822</fpage>&#8211;<lpage>830</lpage>.<pub-id pub-id-type="pmid">10547269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/cyto.1999.0501</pub-id></mixed-citation></ref><ref id="eji70045-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="eji70045-cite-0043"><string-name name-style="western"><given-names>H.</given-names><surname>Wu</surname></string-name>, <string-name name-style="western"><given-names>V.</given-names><surname>Haist</surname></string-name>, <string-name name-style="western"><given-names>W.</given-names><surname>Baumg&#228;rtner</surname></string-name>, and <string-name name-style="western"><given-names>K.</given-names><surname>Schughart</surname></string-name>, &#8220;<article-title>Sustained Viral Load and Late Death in Rag2&#8208;/&#8208; Mice After influenza A Virus Infection</article-title>,&#8221; <source>Virology Journal</source><volume>7</volume> (<year>2010</year>): <fpage>172</fpage>.<pub-id pub-id-type="pmid">20667098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-422X-7-172</pub-id><pub-id pub-id-type="pmcid">PMC2919473</pub-id></mixed-citation></ref><ref id="eji70045-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="eji70045-cite-0044"><string-name name-style="western"><given-names>M. J.</given-names><surname>Cannon</surname></string-name>, <string-name name-style="western"><given-names>E. J.</given-names><surname>Stott</surname></string-name>, <string-name name-style="western"><given-names>G.</given-names><surname>Taylor</surname></string-name>, and <string-name name-style="western"><given-names>B. A.</given-names><surname>Askonas</surname></string-name>, &#8220;<article-title>Clearance of Persistent Respiratory Syncytial Virus Infections in Immunodeficient Mice Following Transfer of Primed T Cells</article-title>,&#8221; <source>Immunology</source><volume>62</volume> (<year>1987</year>): <fpage>133</fpage>&#8211;<lpage>138</lpage>.<pub-id pub-id-type="pmid">3498683</pub-id><pub-id pub-id-type="pmcid">PMC1453729</pub-id></mixed-citation></ref><ref id="eji70045-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="eji70045-cite-0045"><string-name name-style="western"><given-names>J. A.</given-names><surname>Fishman</surname></string-name>, &#8220;<article-title>Infection in Solid&#8208;Organ Transplant Recipients</article-title>,&#8221; <source>New England Journal of Medicine</source><volume>357</volume> (<year>2007</year>): <fpage>2601</fpage>&#8211;<lpage>2614</lpage>.<pub-id pub-id-type="pmid">18094380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMra064928</pub-id></mixed-citation></ref><ref id="eji70045-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="eji70045-cite-0046"><string-name name-style="western"><given-names>B.</given-names><surname>McGrath</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Broadhurst</surname></string-name>, and <string-name name-style="western"><given-names>C.</given-names><surname>Roman</surname></string-name>, &#8220;<article-title>Infectious Disease Considerations in Immunocompromised Patients</article-title>,&#8221; <source>Journal of the American Academy of Physician Assistants</source><volume>33</volume> (<year>2020</year>): <fpage>16</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.JAA.0000694948.01963.f4</pub-id><pub-id pub-id-type="pmid">32841972</pub-id></mixed-citation></ref><ref id="eji70045-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="eji70045-cite-0047"><string-name name-style="western"><given-names>Z.</given-names><surname>Xu</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Shi</surname></string-name>, and <string-name name-style="western"><given-names>Y.</given-names><surname>Wang</surname></string-name>, et&#160;al., &#8220;<article-title>Pathological Findings of COVID&#8208;19 Associated With Acute respiratory Distress Syndrome</article-title>,&#8221; <source>Lancet Respiratory Medicine</source><volume>8</volume> (<year>2020</year>): <fpage>420</fpage>&#8211;<lpage>422</lpage>.<pub-id pub-id-type="pmid">32085846</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-2600(20)30076-X</pub-id><pub-id pub-id-type="pmcid">PMC7164771</pub-id></mixed-citation></ref><ref id="eji70045-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="eji70045-cite-0048"><string-name name-style="western"><given-names>S.</given-names><surname>Nogusa</surname></string-name>, <string-name name-style="western"><given-names>B. W.</given-names><surname>Ritz</surname></string-name>, <string-name name-style="western"><given-names>S. H.</given-names><surname>Kassim</surname></string-name>, <string-name name-style="western"><given-names>S. R.</given-names><surname>Jennings</surname></string-name>, and <string-name name-style="western"><given-names>E. M.</given-names><surname>Gardner</surname></string-name>, &#8220;<article-title>Characterization of Age&#8208;Related Changes in Natural Killer Cells During Primary Influenza Infection in Mice</article-title>,&#8221; <source>Mechanisms of Ageing and Development</source><volume>129</volume> (<year>2008</year>): <fpage>223</fpage>&#8211;<lpage>230</lpage>.<pub-id pub-id-type="pmid">18304606</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mad.2008.01.003</pub-id></mixed-citation></ref><ref id="eji70045-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="eji70045-cite-0049"><string-name name-style="western"><given-names>R. B.</given-names><surname>Reilly</surname></string-name>, <string-name name-style="western"><given-names>S. K.</given-names><surname>Ramdour</surname></string-name>, and <string-name name-style="western"><given-names>M. E.</given-names><surname>Fuhlbrigge</surname></string-name>, et&#160;al., &#8220;<article-title>An Altered Natural Killer Cell Immunophenotype Characterizes Clinically Severe Pediatric RSV Infection</article-title>,&#8221; <source>Science Translational Medicine</source><volume>16</volume> (<year>2024</year>): <fpage>768</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.ado6606</pub-id><pub-id pub-id-type="pmid">39383246</pub-id></mixed-citation></ref><ref id="eji70045-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="eji70045-cite-0050"><string-name name-style="western"><given-names>J.</given-names><surname>Goulding</surname></string-name>, <string-name name-style="western"><given-names>G.</given-names><surname>Abboud</surname></string-name>, <string-name name-style="western"><given-names>V.</given-names><surname>Tahiliani</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Desai</surname></string-name>, <string-name name-style="western"><given-names>T. E.</given-names><surname>Hutchinson</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Salek&#8208;Ardakani</surname></string-name>, &#8220;<article-title>CD8 T Cells Use IFN&#8208;&#947; to Protect Against the Lethal Effects of a Respiratory Poxvirus Infection</article-title>,&#8221; <source>Journal of Immunology</source><volume>192</volume> (<year>2014</year>): <fpage>5415</fpage>&#8211;<lpage>5425</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1400256</pub-id><pub-id pub-id-type="pmcid">PMC4036466</pub-id><pub-id pub-id-type="pmid">24748494</pub-id></mixed-citation></ref><ref id="eji70045-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="eji70045-cite-0051"><string-name name-style="western"><given-names>J.</given-names><surname>Goulding</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Bogue</surname></string-name>, <string-name name-style="western"><given-names>V.</given-names><surname>Tahiliani</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Croft</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Salek&#8208;Ardakani</surname></string-name>, &#8220;<article-title>CD8 T Cells Are Essential for Recovery From a Respiratory Vaccinia Virus Infection</article-title>,&#8221; <source>Journal of Immunology</source><volume>189</volume> (<year>2012</year>): <fpage>2432</fpage>&#8211;<lpage>2440</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1200799</pub-id><pub-id pub-id-type="pmcid">PMC3496758</pub-id><pub-id pub-id-type="pmid">22826318</pub-id></mixed-citation></ref><ref id="eji70045-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="eji70045-cite-0052"><string-name name-style="western"><given-names>N.</given-names><surname>Jaeger</surname></string-name>, <string-name name-style="western"><given-names>A. U.</given-names><surname>Antonova</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Kreisel</surname></string-name>, et&#160;al., &#8220;<article-title>Diversity of Group 1 Innate Lymphoid Cells in human Tissues</article-title>,&#8221; <source>Nature Immunology</source><volume>25</volume> (<year>2024</year>): <fpage>1460</fpage>&#8211;<lpage>1473</lpage>.<pub-id pub-id-type="pmid">38956380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-024-01885-y</pub-id></mixed-citation></ref><ref id="eji70045-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="eji70045-cite-0053"><string-name name-style="western"><given-names>E.</given-names><surname>Vivier</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Artis</surname></string-name>, and <string-name name-style="western"><given-names>M.</given-names><surname>Colonna</surname></string-name>, et&#160;al., &#8220;<article-title>Innate Lymphoid Cells: 10 Years On</article-title>,&#8221; <source>Cell</source><volume>174</volume> (<year>2018</year>): <fpage>1054</fpage>&#8211;<lpage>1066</lpage>.<pub-id pub-id-type="pmid">30142344</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2018.07.017</pub-id></mixed-citation></ref><ref id="eji70045-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="eji70045-cite-0054"><string-name name-style="western"><given-names>T.</given-names><surname>Nabekura</surname></string-name> and <string-name name-style="western"><given-names>A.</given-names><surname>Shibuya</surname></string-name>, &#8220;<article-title>Type 1 Innate Lymphoid Cells: Soldiers at the Front Line of Immunity</article-title>,&#8221; <source>Biomedical Journal</source><volume>44</volume> (<year>2021</year>): <fpage>115</fpage>&#8211;<lpage>122</lpage>.<pub-id pub-id-type="pmid">33839081</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bj.2020.10.001</pub-id><pub-id pub-id-type="pmcid">PMC8178574</pub-id></mixed-citation></ref><ref id="eji70045-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="eji70045-cite-0055"><string-name name-style="western"><given-names>M.</given-names><surname>Sadeghalvad</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Khijakadze</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Orangi</surname></string-name>, and <string-name name-style="western"><given-names>F.</given-names><surname>Takei</surname></string-name>, &#8220;<article-title>Flow Cytometric Analysis of Innate Lymphoid Cells: Challenges and Solutions</article-title>,&#8221; <source>Frontiers in Immunology</source><volume>14</volume> (<year>2023</year>).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2023.1198310</pub-id><pub-id pub-id-type="pmcid">PMC10559883</pub-id><pub-id pub-id-type="pmid">37809100</pub-id></mixed-citation></ref><ref id="eji70045-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="eji70045-cite-0056"><string-name name-style="western"><given-names>O.</given-names><surname>Weizman</surname></string-name>, <string-name name-style="western"><given-names>N. M.</given-names><surname>Adams</surname></string-name>, and <string-name name-style="western"><given-names>I. S.</given-names><surname>Schuster</surname></string-name>, et&#160;al., &#8220;<article-title>ILC1 Confer Early Host Protection at Initial Sites of Viral Infection</article-title>,&#8221; <source>Cell</source><volume>171</volume> (<year>2017</year>): <fpage>795</fpage>&#8211;<lpage>808</lpage>.<pub-id pub-id-type="pmid">29056343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2017.09.052</pub-id><pub-id pub-id-type="pmcid">PMC5687850</pub-id></mixed-citation></ref><ref id="eji70045-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="eji70045-cite-0057"><string-name name-style="western"><given-names>S.</given-names><surname>Ch&#225;vez&#8208;Bueno</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Mej&#237;as</surname></string-name>, and <string-name name-style="western"><given-names>A. M.</given-names><surname>G&#243;mez</surname></string-name>, et&#160;al., &#8220;<article-title>Respiratory Syncytial Virus&#8208;Induced Acute and Chronic Airway Disease Is Independent of Genetic Background: An Experimental Murine Model</article-title>,&#8221; <source>Virology Journal</source><volume>2</volume> (<year>2005</year>): <fpage>46</fpage>.<pub-id pub-id-type="pmid">15916706</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-422X-2-46</pub-id><pub-id pub-id-type="pmcid">PMC1183251</pub-id></mixed-citation></ref><ref id="eji70045-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="eji70045-cite-0058"><string-name name-style="western"><given-names>J.</given-names><surname>Loebbermann</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Thornton</surname></string-name>, and <string-name name-style="western"><given-names>L.</given-names><surname>Durant</surname></string-name>, et&#160;al., &#8220;<article-title>Regulatory T Cells Expressing Granzyme B Play a Critical Role in Controlling Lung Inflammation During Acute Viral Infection</article-title>,&#8221; <source>Mucosal Immunology</source><volume>5</volume> (<year>2012</year>): <fpage>161</fpage>&#8211;<lpage>172</lpage>.<pub-id pub-id-type="pmid">22236998</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mi.2011.62</pub-id><pub-id pub-id-type="pmcid">PMC3282434</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>